RE:Nuggets from prospectusGreat read! With all Pre-Clinical Stage 1 Biotech Companies there is always a chance of a total loss or high reward. PMN has a bright future ahead. Lets look at the numbers for this week and you will notice large Investments were made and many other are Buying. It has been an upwards trend most of this Year and I believe PMN will be safe Investment going forward. PMN310, PMN330 and PMN350 are their Leads.
I do agree for those thinking of Cashing out in the near future, this as of now is a waiting game and will most likely be until The Shelf Prospectus is completed. June 2024 without Revenue.